← Eichor
Study identifier: NCT06912828 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

GWAS to Identify Predictive Genetic Factors for the Success of Dietary Intervention in the Treatment of IBS Symptoms

Condition: Irritable Bowel Syndrome (IBS) · Genome-wide Association Study · Single Nucleotide Polymorphisms  ·  Sponsor: Attikon Hospital

PhaseN/A
Planned participants100
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

This is a GWAS that aims to identify possible single nucleotide polymorphisms (SNPs) that are associated with the response in a combined dietary pattern low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols and Meditteranean diet (MED-LFD) in a small group of patients with Irritable Bowel Syndrome (IBS).

This description comes directly from the study's public registry record.

Talk to the study team

Konstantinos Triantafyllou, Proffesor  ·  +306977402690  ·  ktriant@med.uoa.gr

Maroulla Nikolaki, PhD (c)  ·  +30 6979376752  ·  mnikolaki@med.uoa.gr

Always discuss trial participation with your own doctor first.

Locations (1)

Attikon General University Hospital of AthensAthens, GreeceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06912828